Lipoprotein (a) and family history in six-year-old children from Rivas- Vaciamadrid;Lipoproteina (a) y antecedentes familiares en ninos de 6 anos de Rivas- Vaciamadrid

Anales Espanoles de Pediatria

Volumn 51, Issue 1, 1999, Pages 45-48

  Sanchez Bayle M ^a   Baeza Minguez J ^a   Vila Dupla, S ^a   Arnaiz Rodriguez P ^a   Martin Batanero A ^b   Fernandez Calle M ^b   Anton Pacheco E ^b  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b Hospital del Niño Jesús ^*

Author keywords

Cardiovascular risk factor; Familiar antecedents; Hypercholesterolemia; Lipoprotein (a)

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; LIPOPROTEIN A;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; RISK FACTOR; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; RESIDENTIAL CARE; SENSITIVITY AND SPECIFICITY; SPAIN;

CARDIOVASCULAR DISEASES; CATCHMENT AREA (HEALTH); CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN(A); MALE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 0033158590     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Martínez Triguero ML, Vega García L, Mora Herranz A, Andreu Miquel L, Molina Andreu E: Lipoproteína (a) Química Clínica 1993; 12:414-421.
2. Labeur C, De Bacquer D, De Backer G, Vincke J, Muyldermans L, Vanderkerckhove Y: Plasma lipoprotein (a) values and severity of coronary artery disease in large population of patients undergoing coronary angiography. Clin Chem 1992; 38:2261-2266.
3. Del Río A: Lipoproteína (a). Med Clin (Barc) 1991; 97:453-455.
4. Kostner GM, Czinner A, Pfeiffer KH, Bihari-Varga M: Lipoprotein (a) concentrations as risk indicators for atherosclerosis. Arch Dis Child 1991; 66:1054-1056.
5. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G: Lipoprotein (a) is an independent risk factor for myocardial infarction of a young age. Clin Chem 1990; 36:20-23.
6. Vella JC, Jover E: Relation of lipoprotein(a) in 11 to 19 year-old-adolescents to parental cardiovascular heart disease. Clin Chem 1993; 39:477-480.
7. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS: Racial (black-white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. Circulation 1991; 84:160-167.
8. Wilcken DEL, Li Wang X, Greenwood J, Lynch J: Lipoprotein (a) and A-1 in children and coronary vascular events in their grandparents. J Pediatr 1993; 123:519-526.
9. Siedel J, Schulumberger H, Klose S, Ziegenj-Horn J, Wahiefeld AW: Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Biochem 1981; 19:838-839.
10. Fletcher MJ: Standarization of triglyceride methodology. Ann Clin Lab Sci 1972; 2:389-392.
11. Assman G, Schiewe H, Schnitz G, Haegele D: Quantification of high density lipoprotein cholesterol by precipitation with phosphotungstic acid-Mg-C12. Clin Chem 1983; 29:2026-2030.
12. Friedewald WT, Levu RI, Fredickson DS: Estimation of the concentration of LDL-cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-507.
13. Labeur C, Michiels G, Borg J, Usher D, Rosseneu M: Lipoprotein (a) quantified by an enzyme-linked inmunoabsorbent assay with monoclonal antibodies. Clin Chem 1989; 35:1380-1384.
14. Kwiterovitch PO Jr, Friedrickson DS, Levy RI: Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest 1974; 53:1237-1249.
15. Grupo cooperative español para el estudio de los factores de riesgo cardiovascular en la infancia y adolescencia: Factores de riesgo cardiovascular en la infancia y adolescencia. Estudio Ricardin II:Valores de referencia. An Esp Pediatr 1995; 43:11-17.
16. Rosengren A,Wihelmsen L, Eriksson E, Risberg B, Wedel H: Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J 1990; 301:1248-1251.
17. Mezdour H, Parra HJ, Aguie-Aguie G, Fruchart JC: La lipoproteine (a).Un marqueur additionel de l'atherosclerose. Ann Biol Clin 1990; 48:139-153.
18. Gutiérrez Fuentes JA, Gutiérrez Yago JJ, Díez Monedero E, Alvarez Berceruelo J, Zamorano Curiel P, Tejerina Abanades L: Lipoproteïna Lp(a): factor de riesgo para la aterosclerosis. Med Clin (Barc) 1989; 93:565-567.
19. Farrer M, Game FL, Albers CJ, Neil HAW, Winocour PH, Laker MF, Adams PC, Alberti KGMM: Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease. Br Med J 1993; 307:832-836.
20. Shepherd J: Importance and interaction of genetic and environmental factors in development of atherosclerosis, en Epidemiology, H Vuylsteek, M Hallen (Eds). IOS Press, Brusell, 1994.
21. Sánchez Bayle M, Baeza Mínguez J, Vila Dupla S, Ruiz-Jarabo Quemada C, Asensio Antón J, Arnaiz P, Martín F: Lipoproteína(a) en niños con hipercolesterolemia, como marcador de antecedentes familiares de riesgo cardiovascular. An Esp Pediatr 1996; 45:53-56.
22. Hiraga T, Okubo M, KObayashi T, Nakanishi K, Sugimoto T, Murase T: Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia. Metabolism 1993; 42:1327-1330.
23. Imbew AD, Durrington PN: Lipoprotein (a): Structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990; 85:1-14.
24. Ritter MM, Geiss HC, Richter WO, Schwandt P: Lipoprotein (a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia. Metabolism 1994; 43:572-578.
25. Boyer H, de Gennes JL, Truffert J, Chatellier G, Dairou F, Bruckert E: Lp(a) levels in different types of dyslipidemia in the French population. Atherosclerosis 1990; 85:61-69.